The international independent ranking organisation AD Scientific Index is more than an ordinary "Ranking". The "AD Scientific Index" analyses the academic work of scientists using the H-index, i10 index and number of citations, and provides results that can be used to evaluate the productivity and efficiency of individuals and institutions. In addition to ranking according to "total H-index" for individuals and institutions, you can also see the ranking and analyses according to "last 6 years H-index", "total i10 Productivity index", "last 6 years i10 Productivity index", "total citations" and "last 6 years citations" only in "AD Scientific Index". See also: Subject Rankings, University Subject Rankings and  Universities Rankings 2024 (Sort by: Last 6 years H Index).   Click here for individual or institutional registration.

Total 336 scientist
Total H Index Rankings
University / Institution:
# 1
Country:
# 217
Region:
# 6,024
World:
# 17,820
H-Index
Total:
82
Last 6 Year:
41
Last 6 Year/Total:
0.500
Drug metabolism and disposition
Total H Index Rankings
University / Institution:
# 3
Country:
# 341
Region:
# 8,975
World:
# 26,235
H-Index
Total:
73
Last 6 Year:
38
Last 6 Year/Total:
0.521
Developing inhibitors of the DNA Damage Response into new medicines for cancer patients
Total H Index Rankings
University / Institution:
# 7
Country:
# 601
Region:
# 15,385
World:
# 44,455
H-Index
Total:
61
Last 6 Year:
48
Last 6 Year/Total:
0.787
Clinical Trials
Longitudinal Data
Evidence Synthesis
Total H Index Rankings
University / Institution:
# 8
Country:
# 628
Region:
# 16,136
World:
# 46,581
H-Index
Total:
60
Last 6 Year:
49
Last 6 Year/Total:
0.817
drug discovery and development
viruses and epithelial biology
non coding RNA
post translational modification
Total H Index Rankings
University / Institution:
# 15
Country:
# 974
Region:
# 24,086
World:
# 68,271
H-Index
Total:
53
Last 6 Year:
25
Last 6 Year/Total:
0.472
Total H Index Rankings
University / Institution:
# 16
Country:
# 1,004
Region:
# 24,767
World:
# 70,320
H-Index
Total:
52
Last 6 Year:
35
Last 6 Year/Total:
0.673
meta-analysis
missing data
statistics
biostatistics
miscellaneous statistical theory
Total H Index Rankings
University / Institution:
# 18
Country:
# 1,050
Region:
# 25,892
World:
# 73,434
H-Index
Total:
51
Last 6 Year:
38
Last 6 Year/Total:
0.745
Cancer
Total H Index Rankings
University / Institution:
# 20
Country:
# 1,215
Region:
# 29,906
World:
# 84,041
H-Index
Total:
49
Last 6 Year:
23
Last 6 Year/Total:
0.469
Cardiovascular
Drug Discovery & Development
Total H Index Rankings
University / Institution:
# 22
Country:
# 1,302
Region:
# 31,645
World:
# 88,653
H-Index
Total:
48
Last 6 Year:
21
Last 6 Year/Total:
0.438
Lymphocyte Biology
Lymphomagenesis
Therapeutics
Total H Index Rankings
University / Institution:
# 23
Country:
# 1,320
Region:
# 32,031
World:
# 89,919
H-Index
Total:
47
Last 6 Year:
38
Last 6 Year/Total:
0.809
Total H Index Rankings
University / Institution:
# 29
Country:
# 1,491
Region:
# 36,648
World:
# 102,261
H-Index
Total:
45
Last 6 Year:
28
Last 6 Year/Total:
0.622
Total H Index Rankings
University / Institution:
# 30
Country:
# 1,601
Region:
# 39,090
World:
# 108,945
H-Index
Total:
44
Last 6 Year:
23
Last 6 Year/Total:
0.523
Sustainability
Environmental Risk Assessment
Persistence Assessment
Antimicrobial Resistance
Biodegradability
Total H Index Rankings
University / Institution:
# 32
Country:
# 1,935
Region:
# 46,852
World:
# 130,037
H-Index
Total:
40
Last 6 Year:
35
Last 6 Year/Total:
0.875
Total H Index Rankings
University / Institution:
# 33
Country:
# 1,957
Region:
# 47,385
World:
# 131,519
H-Index
Total:
40
Last 6 Year:
31
Last 6 Year/Total:
0.775
Total H Index Rankings
University / Institution:
# 38
Country:
# 2,067
Region:
# 50,093
World:
# 138,921
H-Index
Total:
39
Last 6 Year:
31
Last 6 Year/Total:
0.795
MS imaging
molecular imaging
Total H Index Rankings
University / Institution:
# 45
Country:
# 2,190
Region:
# 52,851
World:
# 146,521
H-Index
Total:
38
Last 6 Year:
31
Last 6 Year/Total:
0.816
arrhythmias
heart failure
Total H Index Rankings
University / Institution:
# 47
Country:
# 2,305
Region:
# 55,308
World:
# 152,782
H-Index
Total:
38
Last 6 Year:
14
Last 6 Year/Total:
0.368
Diabetes
Cardiovascular disease
Heart failure
Kidney disease
Hypertension
Total H Index Rankings
University / Institution:
# 49
Country:
# 2,328
Region:
# 55,900
World:
# 154,748
H-Index
Total:
37
Last 6 Year:
31
Last 6 Year/Total:
0.838
Lipoproteins
Coronary artery disease
Heart failure
Inflammation
Cardiovascular disease
Total H Index Rankings
University / Institution:
# 52
Country:
# 2,465
Region:
# 59,295
World:
# 163,841
H-Index
Total:
36
Last 6 Year:
30
Last 6 Year/Total:
0.833
Drug discovery and development
Nucleotide therapeutics
Targeted drug delivery
chirality
drug metabolism
Total H Index Rankings
University / Institution:
# 54
Country:
# 2,530
Region:
# 61,016
World:
# 168,275
H-Index
Total:
36
Last 6 Year:
23
Last 6 Year/Total:
0.639
drug discovery
kinase
cell biology
Alzheimer's disease
Total H Index Rankings
University / Institution:
# 56
Country:
# 2,553
Region:
# 61,937
World:
# 170,474
H-Index
Total:
36
Last 6 Year:
18
Last 6 Year/Total:
0.500
Early Phase Oncology
Total H Index Rankings
University / Institution:
# 57
Country:
# 2,632
Region:
# 63,600
World:
# 175,569
H-Index
Total:
35
Last 6 Year:
26
Last 6 Year/Total:
0.743
Diabetes
Total H Index Rankings
University / Institution:
# 61
Country:
# 2,879
Region:
# 69,105
World:
# 190,141
H-Index
Total:
34
Last 6 Year:
20
Last 6 Year/Total:
0.588
Total H Index Rankings
University / Institution:
# 62
Country:
# 2,902
Region:
# 69,648
World:
# 191,417
H-Index
Total:
34
Last 6 Year:
17
Last 6 Year/Total:
0.500
Total H Index Rankings
University / Institution:
# 63
Country:
# 2,933
Region:
# 70,342
World:
# 193,772
H-Index
Total:
33
Last 6 Year:
30
Last 6 Year/Total:
0.909
Total H Index AD Scientific Index - World Scientists Rankings - 2024 H INDEX
University /
Institution
Country Region World Name Country University / Institution Subject Total Last 6 year Last 6 year/total
1 217 6,024 17,820 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

82 41 0.500
3 341 8,975 26,235 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Drug metabolism and disposition |

73 38 0.521
7 601 15,385 44,455 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Developing inhibitors of the DNA Damage Response into new medicines for cancer patients |

61 48 0.787
8 628 16,136 46,581 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Clinical Trials | Longitudinal Data | Evidence Synthesis |

60 49 0.817
15 974 24,086 68,271 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

drug discovery and development | viruses and epithelial biology | non coding RNA | post translational modification |

53 25 0.472
16 1,004 24,767 70,320 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

52 35 0.673
18 1,050 25,892 73,434 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

meta-analysis | missing data | statistics | biostatistics | miscellaneous statistical theory |

51 38 0.745
20 1,215 29,906 84,041 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Cancer |

49 23 0.469
22 1,302 31,645 88,653 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Cardiovascular | Drug Discovery & Development |

48 21 0.438
23 1,320 32,031 89,919 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Lymphocyte Biology | Lymphomagenesis | Therapeutics |

47 38 0.809
Adscientificindex

Click for INSTITUTIONAL BULK REGISTRATION and PREMIUM MEMBERSHIP advantages

Adscientificindex
29 1,491 36,648 102,261 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

45 28 0.622
30 1,601 39,090 108,945 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

44 23 0.523
32 1,935 46,852 130,037 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Sustainability | Environmental Risk Assessment | Persistence Assessment | Antimicrobial Resistance | Biodegradability |

40 35 0.875
33 1,957 47,385 131,519 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

40 31 0.775
38 2,067 50,093 138,921 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

39 31 0.795
45 2,190 52,851 146,521 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

MS imaging | molecular imaging |

38 31 0.816
47 2,305 55,308 152,782 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

arrhythmias | heart failure |

38 14 0.368
49 2,328 55,900 154,748 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Diabetes | Cardiovascular disease | Heart failure | Kidney disease | Hypertension |

37 31 0.838
52 2,465 59,295 163,841 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Lipoproteins | Coronary artery disease | Heart failure | Inflammation | Cardiovascular disease |

36 30 0.833
54 2,530 61,016 168,275 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Drug discovery and development | Nucleotide therapeutics | Targeted drug delivery | chirality | drug metabolism |

36 23 0.639
56 2,553 61,937 170,474 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

drug discovery | kinase | cell biology | Alzheimer's disease |

36 18 0.500
57 2,632 63,600 175,569 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Early Phase Oncology |

35 26 0.743
61 2,879 69,105 190,141 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

Diabetes |

34 20 0.588
62 2,902 69,648 191,417 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

34 17 0.500
63 2,933 70,342 193,772 Sweden Sweden AstraZeneca, Sweden AstraZeneca, Sweden Others

33 30 0.909